Clinical Trials Browser

Phase 2/3 × sulindac sulfone × Gastrointestinal × Clear all

NCT00026468 2013-07-24

Exisulind in Preventing Polyps in Patients With Familial Adenomatous Polyposis

Phase 2/3 Withdrawn

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms